These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 39231089)
1. From Research to Practice: The Latest Data on Evolving Treatments for Chronic Spontaneous Urticaria. Gooderham MJ; Kwatra SG; Geng B J Drugs Dermatol; 2024 Sep; 23(9):795-806. PubMed ID: 39231089 [TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion. Vestergaard C; Toubi E; Maurer M; Triggiani M; Ballmer-Weber B; Marsland A; Ferrer M; Knulst A; Giménez-Arnau A Eur J Dermatol; 2017 Feb; 27(1):10-19. PubMed ID: 27882879 [TBL] [Abstract][Full Text] [Related]
3. Omalizumab in the Treatment of Chronic Urticaria: The Effect of Drug Co-Administration and Co-Morbidities. Tagka A; Lambrou GI; Nicolaidou E; Nakou E; Makris M; Stratigos A; Katsarou A Antiinflamm Antiallergy Agents Med Chem; 2021; 20(1):39-50. PubMed ID: 32013838 [TBL] [Abstract][Full Text] [Related]
4. Current and emerging pharmacotherapy for chronic spontaneous Urticaria: a focus on non-biological therapeutics. Hon KL; Li JTS; Leung AKC; Lee VWY Expert Opin Pharmacother; 2021 Mar; 22(4):497-509. PubMed ID: 32990110 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers to predict therapeutic response in chronic spontaneous urticaria: a review. Gimenez-Arnau AM; Salman A; Podder I Eur J Dermatol; 2024 Feb; 34(1):3-12. PubMed ID: 38557452 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi-center retrospective case series. Ari A; Levy Y; Segal N; Maoz-Segal R; Benor S; Broides A; Horev A; Epstein-Rigbi N; Agmon-Levin N; Marcus N Pediatr Dermatol; 2020 Nov; 37(6):1051-1054. PubMed ID: 32951239 [TBL] [Abstract][Full Text] [Related]
7. Urticaria. Kolkhir P; Giménez-Arnau AM; Kulthanan K; Peter J; Metz M; Maurer M Nat Rev Dis Primers; 2022 Sep; 8(1):61. PubMed ID: 36109590 [TBL] [Abstract][Full Text] [Related]
8. Novel Therapeutic Approaches and Targets for Treatment of Chronic Urticaria: New Insights and Promising Targets for a Challenging Disease. Martina E; Diotallevi F; Bianchelli T; Paolinelli M; Offidani A Curr Pharm Biotechnol; 2021; 22(1):32-45. PubMed ID: 32603278 [TBL] [Abstract][Full Text] [Related]
9. Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don't Know. Terhorst-Molawi D; Fox L; Siebenhaar F; Metz M; Maurer M Am J Clin Dermatol; 2023 May; 24(3):397-404. PubMed ID: 36810982 [TBL] [Abstract][Full Text] [Related]
10. How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and Answers. Türk M; Carneiro-Leão L; Kolkhir P; Bonnekoh H; Buttgereit T; Maurer M J Allergy Clin Immunol Pract; 2020 Jan; 8(1):113-124. PubMed ID: 31374358 [TBL] [Abstract][Full Text] [Related]
11. Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances. Kaplan A; Lebwohl M; Giménez-Arnau AM; Hide M; Armstrong AW; Maurer M Allergy; 2023 Feb; 78(2):389-401. PubMed ID: 36448493 [TBL] [Abstract][Full Text] [Related]
12. Effective treatment of different phenotypes of chronic urticaria with omalizumab: Case reports and review of literature. Kasperska-Zajac A; Jarząb J; Żerdzińska A; Bąk K; Grzanka A Int J Immunopathol Pharmacol; 2016 Jun; 29(2):320-8. PubMed ID: 26729404 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of omalizumab in Chinese patients with anti-histamine refractory chronic spontaneous urticaria. Yuan W; Hu S; Li M; Yang L; Liu L; Zheng M; Guo Z; Song Z; Zhang C; Diao Q; Xu J; Richard A; Patwardhan M; Lyu T; Uddin A; Fogel R; Ligueros-Saylan M; Zheng J Dermatol Ther; 2022 Apr; 35(4):e15303. PubMed ID: 34984792 [TBL] [Abstract][Full Text] [Related]
14. Differences between adult and pediatric chronic spontaneous urticaria from a cohort of 751 patients: Clinical features, associated conditions and indicators of treatment response. Özçeker D; Can PK; Terzi Ö; Ornek SA; Değirmentepe EN; Kızıltac K; Sarac E; Kocatürk E Pediatr Allergy Immunol; 2023 Feb; 34(2):e13925. PubMed ID: 36825740 [TBL] [Abstract][Full Text] [Related]
15. Pediatric chronic spontaneous urticaria: a brief clinician's guide. Votto M; Achilli G; De Filippo M; Licari A; Marseglia A; Moiraghi A; Di Sabatino A; Marseglia GL Expert Rev Clin Immunol; 2022 Sep; 18(9):889-899. PubMed ID: 35833360 [TBL] [Abstract][Full Text] [Related]
16. Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial. Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Canvin J; Maurer M Allergy; 2016 Aug; 71(8):1135-44. PubMed ID: 27010957 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Guidelines-Based Approach to the Treatment of Chronic Spontaneous Urticaria. Sánchez J; Zakzuk J; Cardona R J Allergy Clin Immunol Pract; 2018; 6(1):177-182.e1. PubMed ID: 28709817 [TBL] [Abstract][Full Text] [Related]
18. Are antihistamines still used during omalizumab treatment for chronic spontaneous urticaria? Melé-Ninot G; Serra-Baldrich E; Spertino J; Guilarte M; Ribó González P; Lleonart-Bellfill R; Figueras-Nart I; Bonfill-Ortí M; Depreux N; Sala-Cunill A; Bielsa-Marsol I; Baliu-Piqué C; Sanmartín-Novell V; Garcia-Navarro X; Expósito-Serrano V; Garnica-Velandia D; Diaz-Sarrió MC; Gómez-Armayones S; Gich Saladich I; Giménez-Arnau A Eur J Dermatol; 2022 Sep; 32(5):629-631. PubMed ID: 36468733 [TBL] [Abstract][Full Text] [Related]
19. Chronic Urticaria: An Overview of Treatment and Recent Patents. Hon KL; Leung AKC; Ng WGG; Loo SK Recent Pat Inflamm Allergy Drug Discov; 2019; 13(1):27-37. PubMed ID: 30924425 [TBL] [Abstract][Full Text] [Related]
20. Chronic urticaria in the real-life clinical practice setting in the UK: results from the noninterventional multicentre AWARE study. Savic S; Leeman L; El-Shanawany T; Ellis R; Gach JE; Marinho S; Wahie S; Sargur R; Bewley AP; Nakonechna A; Randall R; Fragkas N; Somenzi O; Marsland A Clin Exp Dermatol; 2020 Dec; 45(8):1003-1010. PubMed ID: 32246853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]